Image pharmaphorum Editor Views & Analysis How big pharma and startups can learn from each other Francesca Wuttke’s varied career has taken her from research roles to private equity and now to the role of chief digital officer at Almirall. Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines. Views & Analysis From narrow AI to broad AI As director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how AI is set to transform life sciences. Views & Analysis Harnessing the potential of AI in commercial life sciences Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years. Load more results
Views & Analysis How big pharma and startups can learn from each other Francesca Wuttke’s varied career has taken her from research roles to private equity and now to the role of chief digital officer at Almirall.
Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
Views & Analysis From narrow AI to broad AI As director of global life sciences at IBM Watson Health, Christina Busmalis is well placed to know how AI is set to transform life sciences.
Views & Analysis Harnessing the potential of AI in commercial life sciences Artificial intelligence (AI) has gained significant momentum in life sciences over the past few years.
News EU clears first drug therapy for rare disease cALD Neuraxpharm and Minoryx' Nezglyal has become the first approved drug therapy in the EU for rare neurodegenerative disease cALD.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
